Beta-Lactam and sulfonamide allergy testing should be a standard of care in immunocompromised host

Tools

Trubiano, J.A., Slavin, M.A., Thursky, K.A., Grayson, M.L. and Phillips, E.J. (2019) Beta-Lactam and sulfonamide allergy testing should be a standard of care in immunocompromised host. The Journal of Allergy and Clinical Immunology: In Practice, 7 (7). pp. 2151-2153.

Link to Published Version: https://doi.org/10.1016/j.jaip.2019.05.051
*Subscription may be required

Abstract

This work was supported by the Austin Medical Research Foundation. J.A.T. is supported by a National Health and Medical Research Council (NHMRC) postgraduate scholarship (GNT 1139902) and a postgraduate scholarship from the National Centre for Infections in Cancer, NHMRC, Centre for Research Excellence (App 1116876). E.J.P. receives grant support from the National Institutes of Health (award nos. 1P50GM115305-01) and the NHMRC.

Item Type:	Journal Article
Murdoch Affiliation:	Institute for Immunology and Infectious Diseases
Publisher:	Elsevier
Copyright:	© 2019 Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
URI:	http://researchrepository.murdoch.edu.au/id/eprint/46313

Item Control Page